表紙
市場調查報告書

新型冠狀病毒感染症 (COVID-19)對經濟的影響,以及GDP、觀光/旅行、醫療市場的預測:2020年∼2025年

Covid-19 Economic Impact and Market Forecasts for Gross Domestic Product, Tourism/travel, and Medical by Country using 3 scenarios. Includes customization with Executive and Consultant Guides. 2020-2025

出版商 Howe Sound Research 商品編碼 926840
出版日期 內容資訊 英文 341 Pages
商品交期: 最快1-2個工作天內
價格
新型冠狀病毒感染症 (COVID-19)對經濟的影響,以及GDP、觀光/旅行、醫療市場的預測:2020年∼2025年 Covid-19 Economic Impact and Market Forecasts for Gross Domestic Product, Tourism/travel, and Medical by Country using 3 scenarios. Includes customization with Executive and Consultant Guides. 2020-2025
出版日期: 2020年03月01日內容資訊: 英文 341 Pages
簡介

新型冠狀病毒感染症 (COVID-19)逐漸演變成大流行。透過掌握風險與可能性,組織可以為變化做準備,並推估產業及國家會受到的影響。

本報告調查了新型冠狀病毒感染症 (COVID-19)對經濟、GDP (國內生產總值)、觀光/旅行市場及醫療市場的影響,並提供病毒概要、冠狀病毒概要、診斷與治療、3種沙盤推演的預測、最新開發動向及主要企業檔案等。

第1章 簡介與市場定義

第2章 大流行的概要

  • 何謂病毒?
    • 病毒是活的嗎?
    • 病毒的結構
    • 病毒的基因組
    • 病毒的變異
  • 冠狀病毒
    • 嚴重急性呼吸道症候群 (SARS)
    • 中東呼吸症候群 (MERS)
    • 新型冠狀病毒感染症 (COVID-19)
  • 大流行的診斷
    • 風險管理
    • 診斷技術:基因組、WGS的功用
    • 診斷技術:免疫測定法
    • 診斷技術:其他
    • 到上市之前的時間、準備的問題
  • 治療
    • 疫苗
    • 疫苗的兩個功用
    • 抗病毒劑

第3章 COVID-19的發展預測

  • 發展預測概要
  • 預測1.抑制蔓延 &早期疫苗
  • 預測2.蔓延持續 & 中期疫苗
  • 預測3.非局部地區的蔓延 & 後期疫苗

第4章 最新開發動向

  • 最新開發動向:重要性及本章的使用法

第5章 主要企業檔案

  • 主要企業:治療
    • Applied DNA Sciences, Inc
    • Codagenix
    • GeoVax Labs, Inc.
    • Takis Biotech
    • Evvivax.
    • Zydus Cadila
    • MIGAL Galilee Research Institute
    • Generex Biotechnology Corporation
    • Moderna Therapeutics.
    • Novavax
    • Bravovax
    • Ascletis Pharma
    • Janssen Pharmaceuticals
    • Altimmune.
    • Greffex Inc.
    • CanSino Biologics, Inc.
    • ExpreS2ion Biotechnologies ApS
    • Clover Biopharmaceuticals.
    • Vaxil Bio Ltd.
    • iBio Pharma Inc.
    • Tonix Pharmaceuticals
    • Curevac
    • ImmunoPrecise
    • X4 Pharmaceuticals
    • Inovio Pharmaceuticals
    • Innovation Pharmaceuticals
    • CytoDyn
    • BIOXYTRAN
    • BioCryst Pharmaceuticals
    • Vir Biotechnology
    • NanoViricides
    • TAKISAWA Technology Co., Ltd.
    • Westway Health
    • Nabriva Therapeutics.
    • Nemesis Bioscience
    • Armata Pharmaceuticals, Inc.
    • Lumavita
    • Priaxon.
    • Union Therapeutics.
    • Enanta Pharmaceuticals, Inc.
    • Demuris
    • Prommune.
    • Vaxart
    • Alexion Pharmaceuticals
    • SelectX Pharmaceuticals, Inc
    • TaiGen Biotechnology Co., Ltd.
    • Abbvie.
    • KYORIN Pharmaceutical Co., Ltd
    • Forge Therapeutics.
    • Alopexx Vaccine LLC.
    • Integrated Biotherapeutics
    • Hennepin Life Sciences
    • Contrafect Corporation.
    • Basilea Pharmaceutica Ltd.
    • AiCuris
    • Redx Pharma Plc/ Redx Anti Infectives Ltd.
    • Centauri Therapeutics Ltd
    • Combioxin SA
    • Mutabilis SAS
    • Vaxdyn
    • Vibiosphen
    • Bioaster
    • Vivexia
    • KBP Biosciences
    • Merck.
    • Symphogen.
    • Johnson & Johnson (Janssen)
    • Pfizer
    • Allergan.
    • GlaxoSmithKline
    • Novartis
    • Gilead Sciences
    • AstraZeneca
    • Sanofi.
    • Shionogi Inc.
    • Cipla
    • DSM Sinochem Pharmaceuticals
    • Wockhardt Ltd.
    • VenatoRx Pharmaceuticals.
  • 主要企業:診斷
    • Abbott Diagnostics.
    • Accelerate Diagnostics
    • Ador Diagnostics
    • Akkoni Biosystems
    • Alveo Technologies
    • Applied BioCode
    • Aus Diagnostics.
    • BD Diagnostics
    • Biocartis
    • BioFire Diagnostics
    • bioMerieux
    • Bio-Rad Laboratories
    • Bosch Healthcare Solutions GmbH
    • Cepheid
    • Co-Diagnostics
    • Cue Health
    • Curetis
    • Diagenode Diagnostics
    • Diascopic
    • Diasorin
    • Expedeon
    • Fusion Genomics.
    • GenePOC Diagnostics.
    • GenMark Dx
    • Hologic
    • Immunexpress
    • Inflammatix
    • Invetech
    • Janssen Diagnostics
    • Karius
    • Lexigene
    • Luminex
    • Mbio Diagnostics
    • Meridian Bioscience.
    • Mesa Biotech
    • Mobidiag.
    • Nanomix
    • Oxford Nanopore
    • Panagene
    • Primerdesign
    • Prominex
    • Qiagen (Statdx)
    • Quantumdx.
    • Quidel
    • Roche Molecular Diagnostics
    • Saw Diagnostics
    • Seegene
    • Sensovation.
    • Siemens Healthineers (Fast Track Diagnostics).
    • SkylineDx
    • Sona Nanotech
    • T2 Biosystems.
    • Thermo Fisher
    • Veradus Labs
    • Veramarx

第6章 COVID-19對GDP產生的經濟影響

  • 經濟影響概要:國別
  • 世界觀光市場:部門別 - 概要
  • 世界醫療市場:部門別 - 概要

第7章 世界觀光市場:部門、發展預測別

  • 飯店
  • 陸上運輸
  • 航空
  • 郵輪觀光市場
  • 其他觀光

第8章 世界醫療市場:部門、發展預測別

  • 治療
  • 診斷
  • PPE
目錄

OVERVIEW:

COVID-19 is turning into a pandemic. Prepare your organization for the changes beginning to take place. Understand the risks and probabilities. Understand how your industry and your nation will be affected. This in-depth report puts you in control of the numbers you need to prepare. Some countries and some industries will be more affected than others. Some may not be affected at all.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

  • i. COVID-19. Strategic Situation Analysis
  • ii. COVID-19. Guidance for Executives
  • iii. COVID-19. Guidance for Management Consultants and Investment Advisors

1. Introduction and Market Definition

  • 1.1. What are Pandemics?
  • 1.2. The Role of Zoonosis
  • 1.3. Market Definition
    • 1.3.1. Revenue Market Size
    • 1.3.2. Gross Domestic Product
    • 1.3.3. Tourism - Hotels
    • 1.3.4. Tourism - Ground
    • 1.3.5. Tourism - Air
    • 1.3.6. Tourism - Cruise
    • 1.3.7. Tourism - Other
    • 1.3.8. Medical - Therapeutic
    • 1.3.9. Medical - Diagnostic
    • 1.3.10. Medical - PPE
  • 1.4. Methodology
    • 1.4.1. Authors
    • 1.4.2. Sources
  • 1.5. Historical Perspective on Pandemics
    • 1.5.1. HIV/AIDS PANDEMIC 2005-2012
    • 1.5.2. FLU PANDEMIC 1968
    • 1.5.3. ASIAN FLU 1956-1958
    • 1.5.4. SPANISH FLU 1918
    • 1.5.5. SIXTH CHOLERA PANDEMIC 1910-1911
    • 1.5.6. FLU PANDEMIC 1889-1890
    • 1.5.7. THE BLACK DEATH 1346-1353

2. The Pandemic Overview

  • 2.1. What is a Virus?
    • 2.1.1. Is a Virus Alive?
    • 2.1.2. Viral Structure
    • 2.1.3. The Viral Genome
    • 2.1.4. Viral Mutation
  • 2.2. The Coronavirus
    • 2.2.1. Severe acute respiratory syndrome (SARS)
    • 2.2.2. Middle East respiratory syndrome (MERS)
    • 2.2.3. Coronavirus disease 2019 (COVID-19)
      • 2.2.3.1. Signs and symptoms
      • 2.2.3.2. Cause
      • 2.2.3.3. Diagnosis
      • 2.2.3.4. Prevention
      • 2.2.3.5. Management
      • 2.2.3.6. Prognosis
      • 2.2.3.7. Epidemiology
      • 2.2.3.10. Misinformation about the outbreak
  • 2.3. Pandemic Diagnostics
    • 2.3.1. Risk Management - Spark and Spread
    • 2.3.2. Dx Technology - Genomic and WGS Role
    • 2.3.3. Dx Technology - Immunoassay
    • 2.3.4. Dx Technology - Other
    • 2.3.5. Time to Market and Preparedness Issues
  • 2.4. Therapeutics
    • 2.4.1. Vaccine
    • 2.4.2. Dual Role of Vaccines
    • 2.4.2. Antiviral

3. COVID-19. Scenarios

  • 3.1. Scenarios Overview
  • 3.2. Scenario 1. Limited Spread & Early Vaccine
  • 3.3. Scenario 2. Contained Spread & Midterm Vaccine
  • 3.4. Scenario 3. Uncontained Spread & Late Vaccine

4. Recent Developments

  • 4.1. Recent Developments - Importance and How to Use This Section
    • 4.1.1. Importance of These Developments
    • 4.1.2. How to Use This Section
      • Generex Signs Contract to Develop a COVID-19 Vaccine
      • Applied DNA, Takis Biotech Partner To Design COVID-19 Vaccines
      • Codagenix Developing a Coronavirus Vaccine
      • Breakthrough From MIGAL Research Institute in Development of COVID-19 Vaccine
      • Novavax Advances Development of Novel COVID-19 Vaccine
      • COVID-19 Causes Air Travel to Fall for first time in 11 Years
      • Steep Drop In Chinese Air Travel Demand
      • New Tech Could Make Coronavirus Vaccine in Record Time
      • Vaxart Announces Initiation of Coronavirus Vaccine Program
      • Coronavirus Detection Test Development by Co-Diagnostics
      • GeoVax, BravoVax to develop vaccine for coronavirus
      • Diagnosing coronavirus in the lab
      • Veredus Lab develops test for coronavirus detection
      • U.S. Pork Producers fear Pandemic
      • First New HIV Strain in 19 Years Identified
      • Flu-Like Epidemic Could Kill 80 Mn Globally
      • Nipah Virus a Global Threat
      • New DRC Ebola cases confirmed as FDA OKs rapid test
      • Ontera Awarded Contract for Zika Genotyping Test
      • Two New Members Join Global Diagnostics Network
      • BARDA Funding Health Security Solutions

5. Profiles of Key Players

  • 5.1. Key Players - Therapeutics
    • Applied DNA Sciences, Inc
    • Codagenix
    • GeoVax Labs, Inc.
    • Takis Biotech
    • Evvivax
    • Zydus Cadila
    • MIGAL Galilee Research Institute
    • Generex Biotechnology Corporation
    • Moderna Therapeutics
    • Novavax
    • Bravovax
    • Ascletis Pharma
    • Janssen Pharmaceuticals
    • Altimmune
    • Greffex Inc.
    • CanSino Biologics, Inc.
    • ExpreS2ion Biotechnologies ApS
    • Clover Biopharmaceuticals
    • Vaxil Bio Ltd.
    • iBio Pharma Inc
    • Tonix Pharmaceuticals
    • Curevac
    • ImmunoPrecise
    • X4 Pharmaceuticals
    • Inovio Pharmaceuticals
    • Innovation Pharmaceuticals
    • CytoDyn
    • BIOXYTRAN
    • BioCryst Pharmaceuticals
    • Vir Biotechnology
    • NanoViricides
    • TAKISAWA Technology Co., Ltd
    • Westway Health
    • Nabriva Therapeutics
    • Nemesis Bioscience
    • Armata Pharmaceuticals, Inc.
    • Lumavita
    • Priaxon
    • Union Therapeutics
    • Enanta Pharmaceuticals, Inc.
    • Demuris
    • Prommune
    • Vaxart
    • Alexion Pharmaceuticals
    • SelectX Pharmaceuticals, Inc
    • TaiGen Biotechnology Co., Ltd.
    • Abbvie
    • KYORIN Pharmaceutical Co., Ltd
    • Forge Therapeutics
    • Alopexx Vaccine LLC
    • Integrated Biotherapeutics
    • Hennepin Life Sciences
    • Contrafect Corporation
    • Basilea Pharmaceutica Ltd.
    • AiCuris
    • Redx Pharma Plc/ Redx Anti Infectives Ltd.
    • Centauri Therapeutics Ltd
    • Combioxin SA
    • Mutabilis SAS
    • Vaxdyn
    • Vibiosphen
    • Bioaster
    • Vivexia
    • KBP Biosciences
    • Merck
    • Symphogen
    • Johnson & Johnson (Janssen)
    • Pfizer
    • Allergan
    • GlaxoSmithKline
    • Novartis
    • Gilead Sciences
    • AstraZeneca
    • Sanofi
    • Shionogi Inc
    • Cipla
    • DSM Sinochem Pharmaceuticals
    • Wockhardt Ltd.
    • VenatoRx Pharmaceuticals
  • 5.2. Key Players - Diagnostics
    • Abbott Diagnostics
    • Accelerate Diagnostics
    • Ador Diagnostics
    • Akkoni Biosystems
    • Alveo Technologies
    • Applied BioCode
    • Aus Diagnostics
    • BD Diagnostics
    • Biocartis
    • BioFire Diagnostics
    • bioMérieux
    • Bio-Rad Laboratories
    • Bosch Healthcare Solutions GmbH
    • Cepheid
    • Co-Diagnostics
    • Cue Health
    • Curetis
    • Diagenode Diagnostics
    • Diascopic
    • Diasorin
    • Expedeon
    • Fusion Genomics.
    • GenePOC Diagnostics
    • GenMark Dx
    • Hologic
    • Immunexpress
    • Inflammatix
    • Invetech
    • Janssen Diagnostics
    • Karius
    • Lexigene
    • Luminex
    • Mbio Diagnostics
    • Meridian Bioscience
    • Mesa Biotech
    • Mobidiag
    • Nanomix
    • Oxford Nanopore
    • Panagene
    • Primerdesign
    • Prominex
    • Qiagen (Statdx)
    • Quantumdx
    • Quidel
    • Roche Molecular Diagnostics
    • Saw Diagnostics
    • Seegene
    • Sensovation
    • Siemens Healthineers (Fast Track Diagnostics)
    • SkylineDx
    • Sona Nanotech
    • T2 Biosystems
    • Thermo Fisher
    • Veradus Labs
    • Veramarx

6. COVID-19. Economic Impact on Gross Domestic Product

  • 6.1. Economic Impact Overview by Country
    • 6.1.1. Table - Economic Impact by Country Scenario 1
    • 6.1.2. Chart - Economic Impact by Country Scenario 1
    • 6.1.3. Table - Economic Impact by Country Scenario 2
    • 6.1.4. Chart - Economic Impact by Country Scenario 2
    • 6.1.5. Table - Economic Impact by Country Scenario 3
    • 6.1.6. Chart - Economic Impact by Country Scenario 3
  • 6.2. Tourism Global Market by Segment - Overview
    • 6.2.1. Table - Tourism Global Market by Segment and Scenario
    • 6.2.2. Chart - Tourism Global Market by Segment and Scenario - 2019/2024 Comparison
    • 6.2.3. Chart - Tourism Global Market by Segment and Scenario - 2019
    • 6.2.4. Chart - Tourism Global Market by Segment and Scenario -2024
    • 6.2.5. Chart - Tourism Global Market by Segment and Scenario - Share by Year
  • 6.3. Medical Global Market by Segment and Scenario - Overview
    • 6.3.1. Table - Medical Global Market by Segment and Scenario
    • 6.3.2. Chart - Medical Global Market by Segment and Scenario - 2019/2024 Comparison
    • 6.3.3. Chart - Medical Global Market by Segment and Scenario - 2019
    • 6.3.4. Chart - Medical Global Market by Segment and Scenario -2024
    • 6.3.5. Chart - Medical Global Market by Segment and Scenario - Share by Year

7. Tourism Global Markets - By Segment and Scenario

  • 7.1. Hotels
    • 7.1.1. Table Hotel Market by Scenario and by Country
    • 7.1.2. Chart - Hotel Market Growth by Scenario
  • 7.2. Ground
    • 7.2.1. Table Ground Market by Scenario and by Country
    • 7.2.2. Chart - Ground Market Growth by Scenario
  • 7.3. Air Travel
    • 7.3.1. Table Air Travel by Scenario and by Country
    • 7.3.2. Chart - Air Travel Growth by Scenario
  • 7.4. Cruise Market
    • 7.4.1. Table Cruise Market by Scenario and by Country
    • 7.4.2. Chart - Cruise Market Growth by Scenario
  • 7.5. Other Tourism
    • 7.5.1. Table Other Tourism by Scenario andby Country
    • 7.5.2. Chart - Other Tourism Growth by Scenario

8. Medical Global Markets - By Segment and Scenario

  • 8.1. Therapeutic
    • 8.1.1. Table Therapeutic Markets by Scenario and by Country
    • 8.1.2. Chart - Therapeutic Markets Growth by Scenario
  • 8.2. Diagnostics
    • 8.2.1. Table Diagnostics Market Growth by Scenario and by Country
    • 8.2.2. Chart - Diagnostics Market Growth by Scenario
  • 8.3. PPE
    • 8.3.1. Table PPE Market by Scenario and by Country
    • 8.3.2. Chart - PPE Market Growth by Scenario

Table of Tables

  • Table 1: Who List of Potential Pandemic Pathogens
  • Table 2: Characteristics of Coronavirus Pandemic Infections
  • Table 3: List of 31 COVID 19 Vaccine Candidates and Companies
  • Table 4: The Three Scenarios
  • Table 5: Scenario 1 Assumptions
  • Table 6: Scenario 1 Country Impact Analysis Table
  • Table 7: Scenario 2 Assumptions
  • Table 8: Scenario 2 Country Impact Analysis Table
  • Table 9: Scenario 3 Assumptions
  • Table 10: Scenario 3 Country Impact Analysis Table
  • Table 11: - Economic Impact by Country Scenario 1
  • Table 12: - Economic Impact by Country Scenario 2
  • Table 13: - Economic Impact by Country Scenario 3
  • Table 14: Tourism Global Market by Segment and Scenario
  • Table 15: Medical Global Market by Segment and Scenario
  • Table 16: Hotel Market by Scenario and by Country
  • Table 17: Ground Market by Scenario and by Country
  • Table 18: Air Travel by Scenario and by Country
  • Table 19: HIV Cruise Market by Scenario and by Country
  • Table 20: Other Tourism by Scenario andby Country
  • Table 21: Therapeutic Markets by Scenario and by Country
  • Table 22: Diagnostics Market Growth by Scenario and by Country
  • Table 23: PPE Market by Scenario and by Country

Table of Figures

  • Figure 1: Global Distribution Pandemic Preparedness
  • Figure 2: Global Pandemic Pathogen Status
  • Figure 3: Estimated Economic Impact of Viral Pandemic by Region
  • Figure 4: Historical Pandemics Infographic
  • Figure 5: Antigenic Drift Creates a new Strain of Virus
  • Figure 6: Structure of Coronaviruses
  • Figure 7: 2019 Economic Impact Chart Scenario 1
  • Figure 8: 2019 Economic Impact Chart Scenario 2
  • Figure 9: 2019 Economic Impact Chart Scenario 3
  • Figure 10: Tourism Global Market by Segment and Scenario - 2019 vs. 2024
  • Figure 11: Tourism Global Market by Segment and Scenario 2019
  • Figure 12: Tourism Global Market by Segment 2024
  • Figure 13: Tourism Global Market by Segment Share by Year
  • Figure 14: Medical Global Market by Segment and Scenario - 2019 vs. 2024
  • Figure 15: Medical Global Market by Segment and Scenario 2019
  • Figure 16: Medical Global Market by Segment and Scenario 2024
  • Figure 17: Hotel Market Growth by Scenario
  • Figure 18: Ground Market Growth by Scenario
  • Figure 19: Air Travel Growth by Scenario
  • Figure 20: Cruise Market Growth by Scenario
  • Figure 21: Other Tourism Growth by Scenario
  • Figure 22: Therapeutic Market Growth by Scenario
  • Figure 23: Diagnostics Market Growth by Scenario
  • Figure 24: PPE Market Growth by Scenario